These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19319184)

  • 1. Neuroendocrine disturbances in Huntington's disease.
    Saleh N; Moutereau S; Durr A; Krystkowiak P; Azulay JP; Tranchant C; Broussolle E; Morin F; Bachoud-Lévi AC; Maison P
    PLoS One; 2009; 4(3):e4962. PubMed ID: 19319184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.
    Kalliolia E; Silajdžić E; Nambron R; Costelloe SJ; Martin NG; Hill NR; Frost C; Watt HC; Hindmarsh P; Björkqvist M; Warner TT
    PLoS One; 2015; 10(10):e0138848. PubMed ID: 26431314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone response to arginine test differentiates between two subgroups of Huntington's disease patients.
    Salvatore E; Rinaldi C; Tucci T; Di Maio L; Di Somma C; Savastano S; Lombardi G; Filla A; Colao A; De Michele G
    J Neurol Neurosurg Psychiatry; 2011 May; 82(5):543-7. PubMed ID: 20884675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease.
    Aziz NA; Pijl H; Frölich M; van der Graaf AW; Roelfsema F; Roos RA
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1223-8. PubMed ID: 19174491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight loss and wrestling training: effects on growth-related hormones.
    Roemmich JN; Sinning WE
    J Appl Physiol (1985); 1997 Jun; 82(6):1760-4. PubMed ID: 9173938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease.
    Aziz NA; Pijl H; Frölich M; Schröder-van der Elst JP; van der Bent C; Roelfsema F; Roos RA
    Eur J Neurol; 2010 Feb; 17(2):280-8. PubMed ID: 19845749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine function following traumatic brain injury and subsequent intensive care treatment: a prospective longitudinal evaluation.
    Kleindienst A; Brabant G; Bock C; Maser-Gluth C; Buchfelder M
    J Neurotrauma; 2009 Sep; 26(9):1435-46. PubMed ID: 19459759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight loss in early stage of Huntington's disease.
    Djoussé L; Knowlton B; Cupples LA; Marder K; Shoulson I; Myers RH
    Neurology; 2002 Nov; 59(9):1325-30. PubMed ID: 12427878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease.
    Popovic V; Svetel M; Djurovic M; Petrovic S; Doknic M; Pekic S; Miljic D; Milic N; Glodic J; Dieguez C; Casanueva FF; Kostic V
    Eur J Endocrinol; 2004 Oct; 151(4):451-5. PubMed ID: 15476444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of functional decline in Huntington's disease. Huntington Study Group.
    Marder K; Zhao H; Myers RH; Cudkowicz M; Kayson E; Kieburtz K; Orme C; Paulsen J; Penney JB; Siemers E; Shoulson I
    Neurology; 2000 Jan; 54(2):452-8. PubMed ID: 10668713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
    Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine abnormalities associated with untreated first episode patients with major depressive disorder and bipolar disorder.
    Feng G; Kang C; Yuan J; Zhang Y; Wei Y; Xu L; Zhou F; Fan X; Yang J
    Psychoneuroendocrinology; 2019 Sep; 107():119-123. PubMed ID: 31125758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic and neuroendocrine changes in Huntington's disease.
    Hult S; Schultz K; Soylu R; Petersén A
    Curr Drug Targets; 2010 Oct; 11(10):1237-49. PubMed ID: 20594177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease - new perspectives based on neuroendocrine changes in rodent models.
    Petersén A; Hult S; Kirik D
    Neurodegener Dis; 2009; 6(4):154-64. PubMed ID: 19521064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults.
    Giannoulis MG; Boroujerdi MA; Powrie J; Dall R; Napoli R; Ehrnborg C; Pentecost C; Cittadini A; Jørgensen JO; Sonksen PH;
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
    Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington's disease.
    Du X; Pang TY; Mo C; Renoir T; Wright DJ; Hannan AJ
    Exp Neurol; 2015 Jan; 263():63-71. PubMed ID: 25246229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.